a year ago
ITGR
AnalystsBrett FishbinBrett Fishbin's Stock Forecasts
AnalystsBrett Fishbin
Analyst Ranking
Bottom 10%
#4788 out of 5296 analysts
Average Return
-2.44%
Win Rate
44%21 out of 48
Risk vs Reward
Poor
Good
Brett Fishbin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Texas Instruments IncTXN | +74.08% | $162.13 | $282.23 | 2025-04-24 - 2026-04-23 | Strong Buy |
Icu Medical IncICUI | +70.01% | $95.00 | $161.51 | 2024-02-06 - 2025-02-05 | Strong Buy |
Integer Holdings CorpITGR | +41.87% | $99.39 | $141.00 | 2024-02-16 - 2025-02-14 | Strong Buy |
Integer Holdings CorpITGR | +35.10% | $105.37 | $142.35 | 2024-02-06 - 2025-02-05 | Strong Buy |
Icu Medical IncICUI | +33.13% | $112.48 | $149.75 | 2024-02-28 - 2025-02-27 | Strong Buy |
Brett Fishbin Analyst Color
Get additional color on Brett Fishbin's coverage of popular stocks
2 years ago
ICUI
2 years ago
ITGR
2 years ago
ICUI
2 years ago
ALC
2 years ago
STE
Brett Fishbin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Steris PLCSTE | 4 | Strong Buy | $269.00 | +29.60% | Maintains | a month ago |
Solventum CorpSOLV | 4 | Strong Buy | $93.00 | +17.92% | Maintains | a month ago |
Resmed IncRMD | 10 | Strong Buy | $290.00 | +48.89% | Maintains | 2 months ago |
Icu Medical IncICUI | 9 | Strong Buy | $164.00 | +15.33% | Maintains | 2 months ago |
Livanova PLCLIVN | 1 | Strong Buy | $81.00 | +2.03% | Initiates Coverage On | 6 months ago |
Integer Holdings CorpITGR | 8 | Strong Buy | $93.00 | +2.22% | Maintains | 8 months ago |
Alcon IncALC | 6 | Strong Buy | $91.00 | +36.13% | Maintains | 8 months ago |
Inspire Medical Systems IncINSP | 5 | Strong Buy | $197.00 | +361.36% | Maintains | a year ago |
Texas Instruments IncTXN | 1 | Strong Buy | $215.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.